NMTRC14: NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)

Go Back to All Clinical Trials

NMTRC14: NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

Conditions:
Neuroblastoma
Age: Between 1 years - 31 years
Gender: Male or Female

Other Inclusion Criteria:

1. Confirmed diagnosis of neuroblastoma. 2. All patients must be in complete remission (CR). 3. No evidence of residual disease by CT/MRI and IBG scan.

You may not be eligible for this study if the following are true:

1. Subjects who are currently receiving another investigation l drug are excluded from participation. 2. Subjects who are currently receiving other anticancer agents are not eligible. 3. Subjects who have an uncontrolled infection are not eligible.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Perlmutter Cancer Center

Clinical Trials & Research Studies